E
EDIT
Editas Medicine Inc
2.63
-0.06-2.04%Opening14:31 09/15 EDT
OPEN/PREV CLOSE2.720/2.690
TODAY RANGE2.603-2.789
VOL767.22K
MARKET CAP236.94M
52 WEEK RANGE0.9101-4.120
AVG VOL (3M)2.37M
% TURNOVER0.85%
TURNOVER--
P/E (TTM)-0.9247
% RANGE6.91%
EPS(TTM)-2.8497
P/E(FORWARD)-1.2608
P/B12.00
BVPS0.2196
DIVIDEND--
P/S6.75
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP236.22M
SHARES OUTSTANDING89.92M
NEXT EARNINGS11/03-11/07
FREE FLOAT89.65M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·6d ago
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Benzinga·09/05 12:01
Editas Medicine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Dow Jones·09/05 11:25
Editas Medicine Price Target Maintained With a $5.00/Share by HC Wainwright & Co.
Reuters·09/04 20:32
Editas Medicine Inc.'s CFO Amy Parison Reports Disposal of Common Shares
Reuters·09/04 20:29
Editas Medicine Inc. CEO Neil O'Neill Reports Disposal of Common Shares
Dow Jones·09/03 13:14
Editas Medicine Is Maintained at Equal-Weight by Wells Fargo
Dow Jones·09/03 13:14
Editas Medicine Price Target Raised to $4.00/Share From $3.00 by Wells Fargo
Benzinga·09/03 13:04
Wells Fargo Maintains Equal-Weight on Editas Medicine, Raises Price Target to $4
TipRanks·09/03 11:46
Truist Financial Sticks to Their Hold Rating for Editas Medicine (EDIT)
TipRanks·09/03 11:17
J.P. Morgan Keeps Their Sell Rating on Editas Medicine (EDIT)
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.